These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19957025)

  • 1. Therapeutic effect of recombinant human catalase on H1N1 influenza-induced pneumonia in mice.
    Shi XL; Shi ZH; Huang H; Zhu HG; Zhou P; Ju D
    Inflammation; 2010 Jun; 33(3):166-72. PubMed ID: 19957025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of recombinant human catalase to suppress inflammation of the murine lung induced by influenza A.
    Shi X; Shi Z; Huang H; Zhu H; Zhou P; Zhu H; Ju D
    Inflammation; 2014 Jun; 37(3):809-17. PubMed ID: 24385240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of recombinant human granulocyte macrophage colony stimulating factor on H1N1 influenza virus-induced pneumonia in mice.
    Huang H; Li H; Zhou P; Ju D
    Cytokine; 2010 Aug; 51(2):151-7. PubMed ID: 20427198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-active protein thioredoxin-1 administration ameliorates influenza A virus (H1N1)-induced acute lung injury in mice.
    Yashiro M; Tsukahara H; Matsukawa A; Yamada M; Fujii Y; Nagaoka Y; Tsuge M; Yamashita N; Ito T; Yamada M; Masutani H; Yodoi J; Morishima T
    Crit Care Med; 2013 Jan; 41(1):171-81. PubMed ID: 23222257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects and related molecular mechanisms of total flavonoids in Mosla chinensis Maxim against H1N1 influenza virus.
    Zhang XX; Wu QF; Yan YL; Zhang FL
    Inflamm Res; 2018 Feb; 67(2):179-189. PubMed ID: 29177921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Bifunctional Fusion Protein, Vunakizumab-IL22, for Protection Against Pulmonary Immune Injury Caused by Influenza Virus.
    Han L; Shi C; Zeng X; Cen L; Mei X; Fan J; Ju D; Zhu H
    Front Immunol; 2021; 12():727941. PubMed ID: 34504501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of influenza virus-caused oxidative stress by Kegan Liyan oral prescription, as monitored by ascorbyl radical ESR signals.
    Duan S; Gu L; Wang Y; Zheng R; Lu J; Yin J; Guli L; Ball M
    Am J Chin Med; 2009; 37(6):1167-77. PubMed ID: 19938224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.
    Nosaka N; Yashiro M; Yamada M; Fujii Y; Tsukahara H; Liu K; Nishibori M; Matsukawa A; Morishima T
    Crit Care; 2015 Jun; 19(1):249. PubMed ID: 26067826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice.
    Kash JC; Xiao Y; Davis AS; Walters KA; Chertow DS; Easterbrook JD; Dunfee RL; Sandouk A; Jagger BW; Schwartzman LM; Kuestner RE; Wehr NB; Huffman K; Rosenthal RA; Ozinsky A; Levine RL; Doctrow SR; Taubenberger JK
    Free Radic Biol Med; 2014 Feb; 67():235-47. PubMed ID: 24140866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia.
    Pulavendran S; Rudd JM; Maram P; Thomas PG; Akhilesh R; Malayer JR; Chow VTK; Teluguakula N
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):689-701. PubMed ID: 31070937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice.
    Sato K; Suga M; Akaike T; Fujii S; Muranaka H; Doi T; Maeda H; Ando M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):853-7. PubMed ID: 9517602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin mediates the pathogenesis of severe 2009 pandemic influenza A(H1N1) infection associated with cytokine dysregulation in mice with diet-induced obesity.
    Zhang AJ; To KK; Li C; Lau CC; Poon VK; Chan CC; Zheng BJ; Hung IF; Lam KS; Xu A; Yuen KY
    J Infect Dis; 2013 Apr; 207(8):1270-80. PubMed ID: 23325916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major shifts in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia.
    Yamada Y; Limmon GV; Zheng D; Li N; Li L; Yin L; Chow VT; Chen J; Engelward BP
    PLoS One; 2012; 7(2):e31494. PubMed ID: 22355371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of endogenous protein C on pulmonary coagulation and injury during lethal H1N1 influenza in mice.
    Schouten M; de Boer JD; van der Sluijs KF; Roelofs JJ; van't Veer C; Levi M; Esmon CT; van der Poll T
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):789-94. PubMed ID: 21330465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Houttuynia cordata polysaccharides ameliorate pneumonia severity and intestinal injury in mice with influenza virus infection.
    Zhu H; Lu X; Ling L; Li H; Ou Y; Shi X; Lu Y; Zhang Y; Chen D
    J Ethnopharmacol; 2018 May; 218():90-99. PubMed ID: 29471085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabexate mesilate suppresses influenza pneumonia in mice through inhibition of cytokines.
    Kosai K; Seki M; Yanagihara K; Nakamura S; Kurihara S; Izumikawa K; Kakeya H; Yamamoto Y; Tashiro T; Kohno S
    J Int Med Res; 2008; 36(2):322-8. PubMed ID: 18380943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacodynamic experiment of the antivirus effect of Houttuynia cordata injection on influenza virus in mice].
    Liu FZ; Shi H; Shi YJ; Liu Y; Jin YH; Gao YJ; Guo SS; Cui XL
    Yao Xue Xue Bao; 2010 Mar; 45(3):399-402. PubMed ID: 21351520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated human catalase elicits potent therapeutic effects on H1N1 influenza-induced pneumonia in mice.
    Shi X; Shi Z; Huang H; Zhu H; Zhu H; Ju D; Zhou P
    Appl Microbiol Biotechnol; 2013 Dec; 97(23):10025-33. PubMed ID: 23525936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H7N9 Influenza Virus Is More Virulent in Ferrets than 2009 Pandemic H1N1 Influenza Virus.
    Yum J; Ku KB; Kim HS; Seo SH
    Viral Immunol; 2015 Dec; 28(10):590-9. PubMed ID: 26421365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.